University of Canterbury Home
    • Admin
    UC Research Repository
    UC Library
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    1. UC Home
    2. Library
    3. UC Research Repository
    4. College of Business and Law
    5. Business and Law: Theses and Dissertations
    6. View Item
    1. UC Home
    2.  > 
    3. Library
    4.  > 
    5. UC Research Repository
    6.  > 
    7. College of Business and Law
    8.  > 
    9. Business and Law: Theses and Dissertations
    10.  > 
    11. View Item

    Data exclusivity for biologics – an emerging multilateral standard? (2020)

    Thumbnail
    View/Open
    Hegedus-Gaspar, Mate_Master's Thesis.pdf (1.437Mb)
    Type of Content
    Theses / Dissertations
    UC Permalink
    https://hdl.handle.net/10092/101334
    http://dx.doi.org/10.26021/10397
    Thesis Discipline
    Law
    Degree Name
    Master of Laws
    Publisher
    University of Canterbury
    Language
    English
    Collections
    • Business and Law: Theses and Dissertations [438]
    Authors
    Hegedus-Gaspar, Mátéshow all
    Abstract

    Biological medicines, or biologics, revolutionised the treatment of some of the most serious medical conditions. These are highly research-intense pharmaceuticals and their development requires enormous expenditure. Countries with strong innovative pharmaceutical industry have been promoting the protection of undisclosed safety and efficacy data relating to biologics by including data protection provisions in regional and bilateral trade agreements. This is a controversial endeavour that not only has been criticised by commentators, but has also led to serious complications in trade negotiations.

    Many countries regulate the protection of clinical data relating to biologics, but it has never been subject to multilateral negotiations. Consequently, while data protection provisions are being routinely included in trade agreements, there is no international consensus on the standard.

    This thesis analyses the phenomenon of an emergent IP protection standard, namely data protection for biologics, and its relationship to the multilateral framework. It explores various aspects and consequences of the paucity of an accepted multilateral standard. Throughout the analysis, it draws attention to the mismatch between the underlying IP principles and the prevalent methods of implementation.

    The thesis proposes a hypothetical multilateral standard by bringing together all theoretical and practical aspects of the analysis, and, finally, demonstrates the utility and practical consequences of the proposed norm.

    Rights
    All Rights Reserved
    https://canterbury.libguides.com/rights/theses
    Advanced Search

    Browse

    All of the RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThesis DisciplineThis CollectionBy Issue DateAuthorsTitlesSubjectsThesis Discipline

    Statistics

    View Usage Statistics
    • SUBMISSIONS
    • Research Outputs
    • UC Theses
    • CONTACTS
    • Send Feedback
    • +64 3 369 3853
    • ucresearchrepository@canterbury.ac.nz
    • ABOUT
    • UC Research Repository Guide
    • Copyright and Disclaimer
    • SUBMISSIONS
    • Research Outputs
    • UC Theses
    • CONTACTS
    • Send Feedback
    • +64 3 369 3853
    • ucresearchrepository@canterbury.ac.nz
    • ABOUT
    • UC Research Repository Guide
    • Copyright and Disclaimer